MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 201 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,040,564 | -17.7% | 566,417 | -7.3% | 0.95% | -22.6% |
| Q1 2023 | $8,556,804 | -35.1% | 610,764 | -33.7% | 1.23% | -33.5% |
| Q4 2022 | $13,184,461 | +16.7% | 921,346 | +108.1% | 1.85% | -1.2% |
| Q3 2022 | $11,302,000 | -7.6% | 442,710 | +2.8% | 1.87% | -20.5% |
| Q2 2022 | $12,229,000 | -17.5% | 430,451 | +2.4% | 2.35% | -8.3% |
| Q1 2022 | $14,829,000 | – | 420,446 | – | 2.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |